Page last updated: 2024-12-07
diphenazine
Description
Diphenazine is an organic compound with the formula C18H14N2. It is a derivative of phenazine, which is a heterocyclic aromatic compound. Diphenazine has been reported to have a wide range of biological activities, including anti-inflammatory, antimicrobial, and anticancer effects. It is synthesized by the reaction of phenazine with an appropriate aryl halide. The synthesis involves the use of a palladium catalyst and a base. The compound is relatively new and is being investigated for its potential medicinal properties. Studies are ongoing to understand its mechanism of action and its safety and efficacy in humans.'
diphenazine: RN given refers to parent cpd; synonym quietidine refers to di-HCl salt; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 94353 |
| MeSH ID | M0059614 |
Synonyms (12)
| Synonym |
|---|
| diphenazine |
| 1,4-bis(1-phenylpropan-2-yl)piperazine |
| unii-8bea88hvgf |
| piperazine, 1,4-bis(1-methyl-2-phenylethyl)- |
| 1,4-bis(1-phenylisopropyl)piperazine |
| 8bea88hvgf , |
| 13838-14-7 |
| quietidine |
| n,n'-bis(phenylisopropyl)piperazine |
| piperazine, 1,4-bis(.alpha.-methylphenethyl)- |
| skf-6591 |
| Q27270140 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 13.13 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.92 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |